Emergence and dissemination of Enterobacteriaceae with plasmid-mediated CMY-6 and CTX-M-15 beta-lactamases in community in North-India

World Journal of Microbiology and Biotechnology

Volumn 25, Issue 8, 2009, Pages 1439-1446

  Shahid, M ^a   Ensor, V M ^b,c   Hawkey, P M ^b,c  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

7 Alpha methoxy cephalosporins; CMY 6 AmpC beta lactamase; Concomitant resistance; CTX M 15 ESBL; India; Oxyimino cephalosporins

Indexed keywords

7-ALPHA-METHOXY-CEPHALOSPORINS; CMY-6 AMPC BETA-LACTAMASE; CONCOMITANT RESISTANCE; CTX-M-15 ESBL; INDIA; OXYIMINO-CEPHALOSPORINS;

ANTIBIOTICS;

ESCHERICHIA COLI;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 70349320140     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-009-0032-4     Document Type: Article

References (27)

1. Abigail S, Mathai E, Jesudason MV, John TJ (1995) Ceftazidime resistance among Klebsiella pneumoniae in south India. Indian J Med Res 102:53-55
2. Alvarez M, Tran JH, Chow N, Jacoby GA (2004) Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob Agents Chemother 48:533-537. doi:10.1128/AAC.48.2.533-537.2004
3. Bauernfeind A, Chong Y, Lee K (1998) Plasmid encoded AmpC beta-lactamases: how far have we gone 10 years after the discovery? Yonsei Med J 39:520-525
4. Bush K, Jacoby GA, Medeiros AA (1995) A functional classification scheme for β-lactamases and its corrilation with molecular structure. Antimicrob Agents Chemother 39:1211-1233
5. Cao VT, Arlet G, Ericsson BM, Tammelin A, Courvalin P, Lambert T (2000) Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J Antimicrob Chemother 46:895-900. doi:10.1093/jac/46.6.895
6. Coudron PE, Hanson ND, Climo MW (2003) Occurrence of extended-spectrum and AmpC β-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC β-lactamases. J Clin Microbiol 41:772-777. doi:10.1128/JCM.41.2.772-777.2003
7. Davis LG, Dibner MD, Battey JF (1986) Large scale alkaline lysis method of plasmid purification. In: Davis LG, Dibner MD, Battey JF (eds) Basic methods in molecular biology, Sect. 8-3. Elsevier, New York, p 99
8. Ensor VM, Shahid M, Evans JT, Hawkey PM (2006a) Occurrence, prevalence and genetic environment of CTX-M beta-lactamase in Enterobacteriaceae from Indian hospitals. J Antimicrob Chemother 58:1260-1263. doi:10.1093/jac/dkl422
9. Ensor VM, Shahid M, Hope R, Warner M, Woodford N, Livermore DM, Hawkey PM (2006b) Novel reverse line hybridization assay to identify CTX-M genotype in cephalosporin-resistant isolates from UK and India. Clin Microbiol Infect 12(suppl 4):1750
10. Gazouli M, Tzouvelekis LS, Prinarakis E, Miriagou V, Tzelepi E (1996) Transferable cefoxitin resistance in Enterobacteria from Greek hospitals and characterization of a plasmid-mediated Group 1 β-lactamase (LAT-2). Antimicrob Agents Chemother 40:1736-1740
11. Girlich D, Naas T, Bellais S, Poirel L, Karim A, Nordmann P (2000) Heterogeneity of AmpC cephalosporinases of Hafnia alvei clinical isolates expressing inducible or constitutive ceftazidime resistance phenotypes. Antimicrob Agents Chemother 44:3220-3223. doi:10.1128/AAC.44.11.3220-3223.2000
12. Hanson ND (2003) AmpC β-lactamases: what do we need to know for the future. J Antimicrob Chemother 52:2-4. doi:10.1093/jac/dkg284
13. M'Zali FH, Heritage J, Gascoyne-Binzi DM, Denton M, Todd NJ, Hawkey PM (1997) Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type β-lactamase exposed during an outbreak of SHV-5 extended-spectrum β-lactamase in Leeds hospital. J Antimicrob Chemother 40:823-831. doi:10.1093/jac/40.6.823
14. Manchanda V, Singh NP (2003) Occurrence and detection of AmpC β-lactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India. J Antimicrob Chemother 51:415-418. doi:10.1093/jac/dkg098
15. Moland ES, Black JA, Ourada J, Reisbig MD, Hanson ND, Thomson KS (2002) Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 US hospitals. Antimicrob Agents Chemother 46:3837-3842. doi:10.1128/AAC.46.12.3837-3842.2002
16. National committee for clinical laboratory standards (2003) Performance standards for antimicrobial disk susceptibility tests. Approved standard. NCCLS document M2-A8, 8th edn. National Committee for Clinical Laboratory Standards, Wayne
17. Perez-Perez FJ, Hanson ND (2002) Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40:2153-2162. doi:10.1128/JCM.40.6.2153-2162.2002
18. Philippon A, Arlet G, Jacoby GA (2002) Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 46:1-11. doi:10.1128/AAC.46.1.1-11.2002
19. Potz NAC, Hope R, Warner M, Johnson AP, Livermore DM, on behalf of the London and South East ESBL Project Group (2006) Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J Antimicrob Chemother 58:320-326. doi:10.1093/jac/dkl217
20. Shahid M, Malik A, Sheeba (2003) Multi-drug resistant Pseudomonas aeruginosa strains harbouring R-plasmids and Amp C β-lactamase isolated from hospitalised burn patients in a tertiary care hospital of North India. FEMS Microbiol Lett 228:181-186. doi:10.1016/S0378-1097(03)00756-0
21. Shahid M, Malik A, Agrawal M, Singhal S (2004) Phenotypic detection of the extended-spectrum and AmpC β-lactamases by a new spot inoculation method and modified three-dimensional extract test: comparison with conventional three-dimensional extract test. J Antimicrob Chemother 54:684-687. doi:10.1093/jac/dkh389
22. Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M (2008) Prevalent phenotypes and antibiotics resistance in Escherichia coli and Klebsiella pneumoniae in an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance. Int J Infect Dis 12:256-264. doi:10.1016/j.ijid.2007.08.008
23. Song W, Bae IK, Lee Y-N, Lee C-H, Lee SH, Jeong SH (2007) Detection of extended-spectrum β-lactamases by using boronic acid as an AmpC β-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J Clin Microbiol 45:1180-1184. doi:10.1128/JCM.02322-06
24. Subha A, Devi VR, Ananthan S (2003) AmpC β-lactamase producing multidrug resistant strains of Klebsiella ssp. & Escherichia coli isolated from children under five in Chennai. Indian J Med Res 117:13-18
25. Thomson KS (2001) Controversies about extended-spectrum and AmpC beta-lactamases. Emerg Infect Dis 7:333-336
26. Thomson KS, Moland ES (2000) Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of new millennium. Microbes Infect 2:1225-1235. doi:10.1016/S1286-4579(00)01276-4
27. Yum JH, Kim S, Lee H, Yong D, Lee K, Cho S-N, Chong Y (2005) Emergence and wide dissemination of CTX-M-type ESBLs, and CMY-2- and DHA-1-type AmpC β-lactamases in Korean respiratory isolates of Klebsiella pneumoniae. J Korean Med Sci 20:961-965